Chapman v. Procter & Gamble Distributing, LLC
Certiorari Denied
Petition for certiorari denied on May 18, 2015.
Issue
Whether Federal Rule of Evidence 702, as interpreted by Daubert v. Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease.
Nov 26, 2014Application (14A563) to extend the time to file a petition for a writ of certiorari from December 10, 2014 to February 6, 2015, submitted to Justice Thomas.
Dec 3, 2014Application (14A563) granted by Justice Thomas extending the time to file until February 6, 2015.
Feb 6, 2015Petition for a writ of certiorari filed. (Response due March 11, 2015)
Mar 6, 2015Order extending time to file response to petition to and including April 10, 2015.
Apr 10, 2015Brief of respondents Procter & Gamble Distributing, LLC, et al. in opposition filed.
Apr 28, 2015DISTRIBUTED for Conference of May 14, 2015.
Apr 28, 2015Reply of petitioners Marianne Chapman and Daniel Chapman filed. (Distributed)May 18, 2015Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Recommended Citation: Chapman v. Procter & Gamble Distributing, LLC, SCOTUSblog, https://www.scotusblog.com/cases/chapman-v-procter-gamble-distributing-llc/